INNMI Peptide recently announced a further expansion of its peptide product portfolio and specifications, alongside upgrades to its contract manufacturing, customized production, packaging support, and long-term supply services. The company currently offers 87 major product categories and more than 180 SKUs and specification records, with its business reaching over 35 markets worldwide. Rather than simply increasing the number of available products, the latest expansion is focused on improving the entire service chain, from product selection and manufacturing to delivery, in order to meet the increasingly diverse sourcing requirements of international brands and distribution partners.
As the market for related products becomes increasingly segmented, customers are placing greater emphasis on a broader range of supplier capabilities, including product specifications, batch documentation, manufacturing capacity, customization efficiency, and supply continuity. As a result, suppliers with flexible manufacturing capabilities and OEM/ODM services are attracting greater attention.
Founded in Hong Kong in 2019, INNMI Peptide specializes in peptide product development and manufacturing services. Its business covers OEM/ODM, specification customization, private labeling, packaging solutions, bulk production, and long-term supply. Supported by manufacturing facilities operating in accordance with GMP standards, the company provides production solutions tailored to customers of different sizes and requirements.
A key aspect of the latest portfolio expansion is the broader selection of products and specifications available to customers, while incorporating the purchasing requirements of businesses at different stages of development into its manufacturing service system. Customers in the early stages of brand development can select standard products, commonly requested specifications, and standardized packaging according to their needs. Customers with established distribution channels and larger order volumes can access bulk manufacturing, customized packaging, and ongoing supply services.
At the same time, INNMI Peptide is strengthening batch management and documentation support throughout its production processes. According to the company, relevant records are maintained across key stages including raw material handling, processing, purification, lyophilization, and quality testing. A product batch traceability system has also been established. Depending on the specific product and batch, the company can provide Certificates of Analysis (COAs) and other relevant testing documentation. For international customers, such documentation can support information verification throughout procurement, inventory management, and downstream distribution processes.
Enhancing manufacturing service capabilities is another important component of the company’s latest business expansion. Compared with simply supplying standardized products, contract manufacturing and customized production require suppliers to coordinate product specifications, production scheduling, packaging, and delivery management. Through its flexible manufacturing model, INNMI Peptide provides production solutions for customers with varying procurement volumes, allowing brand partners to dedicate more resources to marketing and distribution development.
Industry observers note that companies combining a diversified product portfolio with flexible manufacturing, quality management, and documentation support are better positioned to address the long-term requirements of brands and distribution partners. By expanding its peptide product portfolio and enhancing its manufacturing services, INNMI Peptide is further strengthening its ability to serve customers across global markets while creating additional opportunities for OEM/ODM partnerships and long-term supply relationships.